Sugammadex Versus Neostigmine for Reversal of Rocuronium Neuromuscular
Clinical trial NCT03322657 · COMPLETED
Trial details
- NCT number
- NCT03322657
- Sponsor
- The Cleveland Clinic
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2017-11-14
- Primary completion
- 2020-12-31
- Enrollment
- 69
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.